405 related articles for article (PubMed ID: 35421148)
1. Health economic evaluation of noninvasive prenatal testing and serum screening for down syndrome.
Xiao G; Zhao Y; Huang W; Hu L; Wang G; Luo H
PLoS One; 2022; 17(4):e0266718. PubMed ID: 35421148
[TBL] [Abstract][Full Text] [Related]
2. The consequences of implementing non-invasive prenatal testing in Dutch national health care: a cost-effectiveness analysis.
Beulen L; Grutters JP; Faas BH; Feenstra I; van Vugt JM; Bekker MN
Eur J Obstet Gynecol Reprod Biol; 2014 Nov; 182():53-61. PubMed ID: 25238658
[TBL] [Abstract][Full Text] [Related]
3. Prenatal screening for fetal aneuploidy in singleton pregnancies.
Chitayat D; Langlois S; Douglas Wilson R; ;
J Obstet Gynaecol Can; 2011 Jul; 33(7):736-750. PubMed ID: 21749752
[TBL] [Abstract][Full Text] [Related]
4. Clinical performance of non-invasive prenatal served as a first-tier screening test for trisomy 21, 18, 13 and sex chromosome aneuploidy in a pilot city in China.
Liu Y; Liu H; He Y; Xu W; Ma Q; He Y; Lei W; Chen G; He Z; Huang J; Liu J; Liu Y; Huang Q; Yu F
Hum Genomics; 2020 Jun; 14(1):21. PubMed ID: 32503639
[TBL] [Abstract][Full Text] [Related]
5. A Cost-Effectiveness Analysis of Screening Strategies Involving Non-Invasive Prenatal Testing for Trisomy 21.
Wang S; Liu K; Yang H; Ma J
Front Public Health; 2022; 10():870543. PubMed ID: 35712262
[TBL] [Abstract][Full Text] [Related]
6. Clinical utility and cost of non-invasive prenatal testing with cfDNA analysis in high-risk women based on a US population.
Song K; Musci TJ; Caughey AB
J Matern Fetal Neonatal Med; 2013 Aug; 26(12):1180-5. PubMed ID: 23356557
[TBL] [Abstract][Full Text] [Related]
7. Cost-effectiveness of prenatal screening and diagnostic strategies for Down syndrome: A microsimulation modeling analysis.
Zhang W; Mohammadi T; Sou J; Anis AH
PLoS One; 2019; 14(12):e0225281. PubMed ID: 31800591
[TBL] [Abstract][Full Text] [Related]
8. Introducing the non-invasive prenatal test for trisomy 21 in Belgium: a cost-consequences analysis.
Neyt M; Hulstaert F; Gyselaers W
BMJ Open; 2014 Nov; 4(11):e005922. PubMed ID: 25380810
[TBL] [Abstract][Full Text] [Related]
9. Noninvasive Prenatal Testing for Trisomies 21, 18, and 13, Sex Chromosome Aneuploidies, and Microdeletions: A Health Technology Assessment.
Health Quality Ontario
Ont Health Technol Assess Ser; 2019; 19(4):1-166. PubMed ID: 30847010
[TBL] [Abstract][Full Text] [Related]
10. Study on the Clinical Value of Noninvasive Prenatal Testing in Screening the Chromosomal Abnormalities of the Fetus in the Elderly Pregnant Women.
Gu Z; Du M; Xu T; Jin C
Comput Math Methods Med; 2022; 2022():2977128. PubMed ID: 36213582
[TBL] [Abstract][Full Text] [Related]
11. Cost-Effectiveness Analysis of Non-invasive Prenatal Testing for Down Syndrome in China.
Xu Y; Wei Y; Ming J; Li N; Xu N; Pong RW; Chen Y
Int J Technol Assess Health Care; 2019 Jan; 35(3):237-242. PubMed ID: 31131776
[TBL] [Abstract][Full Text] [Related]
12. Discordant performances of non-invasive prenatal testing for foetal trisomy 21 screening in subgroups of pregnancies.
Suo F; Wang Y; Wang N; Wang Y; Liao M; Wang J; Wang C; Zhang Y; Zhang M; Zhang C; Gu M; Gou L
J Obstet Gynaecol; 2023 Dec; 43(2):2288226. PubMed ID: 38054928
[TBL] [Abstract][Full Text] [Related]
13. [Retrospective analysis for 424 330 first-line screening results of non-invasive prenatal testing in Hebei province].
Liu J; Zhao JH; Chu W; Jiao HY; Hao GM; Gao J
Zhonghua Fu Chan Ke Za Zhi; 2022 Dec; 57(12):900-906. PubMed ID: 36562223
[No Abstract] [Full Text] [Related]
14. Model-based analysis of costs and outcomes of non-invasive prenatal testing for Down's syndrome using cell free fetal DNA in the UK National Health Service.
Morris S; Karlsen S; Chung N; Hill M; Chitty LS
PLoS One; 2014; 9(4):e93559. PubMed ID: 24714162
[TBL] [Abstract][Full Text] [Related]
15. The consequences of implementing non-invasive prenatal testing with cell-free foetal DNA for the detection of Down syndrome in the Spanish National Health Service: a cost-effectiveness analysis.
Bayón JC; Orruño E; Portillo MI; Asua J
Cost Eff Resour Alloc; 2019; 17():6. PubMed ID: 30867656
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of the Z-score accuracy of noninvasive prenatal testing for fetal trisomies 13, 18 and 21 at a single center.
Junhui W; Ru L; Qiuxia Y; Dan W; Xiuhong S; Yongling Z; Xiangyi J; Fatao L; Xuewei T; Guilan C; Fan J; Fucheng L; Fang F; Yan L; Lina Z; Cuixing Y; Jian L; Dongzhi L; Can L
Prenat Diagn; 2021 May; 41(6):690-696. PubMed ID: 33480032
[TBL] [Abstract][Full Text] [Related]
17. [Clinical application and evaluation of health economics for non-invasive prenatal testing of fetuses in Tianjin].
Ma R; Li X; Xu S; Shi Y; Ju D; Li Y; Meng F; Wang X; Du X; Xu N; Zhang Y
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2023 Feb; 40(2):135-142. PubMed ID: 36709929
[TBL] [Abstract][Full Text] [Related]
18. Effect of maternal age on foetal chromosomal defects: an investigation based on non-invasive prenatal testing.
Li ZQ; Kang WL; Tang SJ; Mao Y; Fang T; Jiang JJ; Li XH
J Obstet Gynaecol; 2023 Dec; 43(2):2287125. PubMed ID: 38069630
[TBL] [Abstract][Full Text] [Related]
19. Noninvasive prenatal testing in routine clinical practice--an audit of NIPT and combined first-trimester screening in an unselected Australian population.
McLennan A; Palma-Dias R; da Silva Costa F; Meagher S; Nisbet DL; Scott F
Aust N Z J Obstet Gynaecol; 2016 Feb; 56(1):22-8. PubMed ID: 26817523
[TBL] [Abstract][Full Text] [Related]
20. Contingent first-trimester screening for aneuploidies with cell-free DNA in a Danish clinical setting.
Miltoft CB; Rode L; Ekelund CK; Sundberg K; Kjaergaard S; Zingenberg H; Tabor A
Ultrasound Obstet Gynecol; 2018 Apr; 51(4):470-479. PubMed ID: 28640470
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
